國立虎尾科技大學 |

Vaccines, Medicines and COVID-19 = How Can WHO Be Given a Stronger Voice? /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Vaccines, Medicines and COVID-19/ by Germán Velásquez.
其他題名:	How Can WHO Be Given a Stronger Voice? /
作者:	Velásquez, Germán.
面頁冊數:	XVI, 117 p.online resource. :
Contained By:	Springer Nature eBook
標題:	Public Health. -
電子資源:	https://doi.org/10.1007/978-3-030-89125-1
ISBN:	9783030891251

Vaccines, Medicines and COVID-19 = How Can WHO Be Given a Stronger Voice? /
Velásquez, Germán.

Vaccines, Medicines and COVID-19How Can WHO Be Given a Stronger Voice? /[electronic resource] :by Germán Velásquez. - 1st ed. 2022. - XVI, 117 p.online resource. - SpringerBriefs in Public Health,2192-3701. - SpringerBriefs in Public Health,.

Chapter 1: COVID-19 Vaccines: Between Ethics, Health and Economics -- Chapter 2: Medicines and Intellectual Property: 10 Years of the WHO Global Strategy -- Chapter 3: Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 -- Chapter 4: Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock -- Chapter 5: Intellectual Property and Access to Medicines and Vaccines -- Chapter 6: The World Health Organization Reforms in the Time of COVID-19 -- Epilogue.

Open Access

This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.

ISBN: 9783030891251

Standard No.: 10.1007/978-3-030-89125-1doiSubjects--Topical Terms:

592982
Public Health.

LC Class. No.: RA421-790.95

Dewey Class. No.: 613

Vaccines, Medicines and COVID-19 = How Can WHO Be Given a Stronger Voice? /
LDR:03942nam a22004335i 4500 001 1091984
003 DE-He213
005 20221110144844.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030891251 $9 978-3-030-89125-1
024 7 $a 10.1007/978-3-030-89125-1 $2 doi
035 $a 978-3-030-89125-1
050 4 $a RA421-790.95
072 7 $a MBN $2 bicssc
072 7 $a MED076000 $2 bisacsh
072 7 $a MBN $2 thema
082 0 4 $a 613 $2 23
082 0 4 $a 614.4 $2 23
100 1 $a Velásquez, Germán. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1399687
245 1 0 $a Vaccines, Medicines and COVID-19 $h [electronic resource] : $b How Can WHO Be Given a Stronger Voice? / $c by Germán Velásquez.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XVI, 117 p. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a SpringerBriefs in Public Health, $x 2192-3701
505 0 $a Chapter 1: COVID-19 Vaccines: Between Ethics, Health and Economics -- Chapter 2: Medicines and Intellectual Property: 10 Years of the WHO Global Strategy -- Chapter 3: Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 -- Chapter 4: Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock -- Chapter 5: Intellectual Property and Access to Medicines and Vaccines -- Chapter 6: The World Health Organization Reforms in the Time of COVID-19 -- Epilogue.
506 0 $a Open Access
520 $a This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.
650 2 4 $a Public Health. $3 592982
650 2 4 $a Biomaterials-Vaccines. $3 1394946
650 2 4 $a Health Policy. $3 577593
650 1 4 $a Health Promotion and Disease Prevention. $3 593964
650 0 $a Public health. $3 560998
650 0 $a Biomaterials. $3 677000
650 0 $a Vaccines—Biotechnology. $3 1394945
650 0 $a Medical policy. $3 570081
650 0 $a Health promotion. $3 565089
650 0 $a Medicine, Preventive. $3 582813
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030891244
776 0 8 $i Printed edition: $z 9783030891268
830 0 $a SpringerBriefs in Public Health, $x 2192-3698 $3 1253815
856 4 0 $u https://doi.org/10.1007/978-3-030-89125-1
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
912 $a ZDB-2-SOB
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)